Abstract

This dissertation is focused on the functional characterization of
NCOA4 protein, and in particular on its role in controlling DNA replication in
HeLa cells.
In human papillary thyroid carcinoma the rearrangement of RET
protooncogene, in particular of its tyrosine kinase domain, with the 5’ portion
of a number of heterologous genes, generates the RET/papillary thyroid
carcinoma (PTC) oncogenes. One of the most frequent and aggressive variants
of these recombination events is the fusion of the intracellular kinase-encoding
domain of RET to the first 238 amino acids of a gene named NCOA4
(ELE1/ARA70/RFG), generating the RET/PTC3 oncogene.
We previously isolated the Mini-Chromosome Maintenance 7 (MCM7) protein
as an interactor of NCOA4.
MCM7 is a component of an heteroexameric complex named MCM2-7,
considered a master regulator of DNA replication, acting both during DNA
replication origins licensing, as part of the Pre-Replication Complex (Pre-RC),
and during nascent strand elongation, as the major helicase of the fork. In
Xenopus laevis egg extracts NCOA4 blocks DNA replication. Hindrance of
DNA replication is mediated by block of MCM2-7 helicase function, leaving
untouched origin licensing and activation.
Here we show that NCOA4 and MCM7 proteins interact at the
endogenous level in HeLa cells and this interaction is confined in the nucleus
and takes place preferentially on chromatin.
Moreover, in HeLa cells, NCOA4 binds canonical DNA replication origins,
such as those prospicient to the c-Myc or to the Lamin B2 gene.
RNAi-mediated depletion of NCOA4 accelerates the onset of DNA replication,
whereas adoptive NCOA4 overexpression decreases cell growth and DNA
synthesis.
Our results suggest that NCOA4/RET rearrangement might represent a
novel paradigm of a cancer-associated chromosome rearrangement that directly
targets a gene that controls cell proliferation.